BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25252047)

  • 1. Munc13-4 deficiency with CD5 downregulation on activated CD8+ T cells.
    Wada T; Yasumi T; Toma T; Hori M; Maeda S; Umeda K; Heike T; Adachi S; Usami I; Yachie A
    Pediatr Int; 2014 Aug; 56(4):605-8. PubMed ID: 25252047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations.
    Wada T; Sakakibara Y; Nishimura R; Toma T; Ueno Y; Horita S; Tanaka T; Nishi M; Kato K; Yasumi T; Ohara O; Yachie A
    Hum Immunol; 2013 Dec; 74(12):1579-85. PubMed ID: 24051121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of CD5 and dysregulated CD8
    Wada T
    Pediatr Int; 2018 Sep; 60(9):776-780. PubMed ID: 29920868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL).
    Ueda I; Ishii E; Morimoto A; Ohga S; Sako M; Imashuku S
    Pediatr Blood Cancer; 2006 Apr; 46(4):482-8. PubMed ID: 16365863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
    Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
    J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea.
    Seo JY; Song JS; Lee KO; Won HH; Kim JW; Kim SH; Lee SH; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Han DK; Kook H; Hwang TJ; Lyu CJ; Lee MJ; Kim JY; Park SS; Lim YT; Kim BE; Koh KN; Im HJ; Seo JJ; Kim HJ;
    Ann Hematol; 2013 Mar; 92(3):357-64. PubMed ID: 23180437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a large UNC13D gene duplication in a patient with familial hemophagocytic lymphohistiocytosis type 3.
    Hiejima E; Shibata H; Yasumi T; Shimodera S; Hori M; Izawa K; Kawai T; Matsuoka M; Kojima Y; Ohara A; Nishikomori R; Ohara O; Heike T
    Clin Immunol; 2018 Jun; 191():63-66. PubMed ID: 29596912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CTL-based functional analysis shows the reliability of a munc13-4 protein expression assay for FHL3 diagnosis.
    Shibata H; Yasumi T; Shimodera S; Hiejima E; Izawa K; Kawai T; Shirakawa R; Wada T; Nishikomori R; Horiuchi H; Ohara O; Ishii E; Heike T
    Blood; 2018 May; 131(18):2016-2025. PubMed ID: 29549174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angeborene hämophagozytische Lymphohistiozytose (HLH).
    Pachlopnik Schmid J; de Saint Basile G
    Klin Padiatr; 2010 Nov; 222(6):345-50. PubMed ID: 20458667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions.
    Ishii E; Ueda I; Shirakawa R; Yamamoto K; Horiuchi H; Ohga S; Furuno K; Morimoto A; Imayoshi M; Ogata Y; Zaitsu M; Sako M; Koike K; Sakata A; Takada H; Hara T; Imashuku S; Sasazuki T; Yasukawa M
    Blood; 2005 May; 105(9):3442-8. PubMed ID: 15632205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease.
    Marcenaro S; Gallo F; Martini S; Santoro A; Griffiths GM; Aricó M; Moretta L; Pende D
    Blood; 2006 Oct; 108(7):2316-23. PubMed ID: 16778144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CD57
    Hori M; Yasumi T; Shimodera S; Shibata H; Hiejima E; Oda H; Izawa K; Kawai T; Ishimura M; Nakano N; Shirakawa R; Nishikomori R; Takada H; Morita S; Horiuchi H; Ohara O; Ishii E; Heike T
    J Clin Immunol; 2017 Jan; 37(1):92-99. PubMed ID: 27896523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Genetic Analysis of Nine Suspected Familial Haemophagocytic Lymphohistiocytosis Patients for MUNC13-4 Deficiency and Introducing Four Novel Mutations in UNC13D.
    Vahidi M; Badalzadeh M; Jannesar M; Mazinani M; Fazlollahi MR; Khodayari Namini N; Houshmand M; Hamidieh AA; Moradi L; Pourpak Z; Moin M
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):487-492. PubMed ID: 32245292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis.
    Li X; Wirtz T; Weber T; Lebedin M; Lowenstein ED; Sommermann T; Zach A; Yasuda T; de la Rosa K; Chu VT; Schulte JH; Müller I; Kocks C; Rajewsky K
    Sci Immunol; 2024 Feb; 9(92):eadi0042. PubMed ID: 38306418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Spectrum of Clinical, Immunological, and Molecular Findings in Familial Hemophagocytic Lymphohistiocytosis: Experience From India.
    Shabrish S; Kelkar M; Yadav RM; Bargir UA; Gupta M; Dalvi A; Aluri J; Kulkarni M; Shinde S; Sawant-Desai S; Kambli P; Hule G; Setia P; Jodhawat N; Gaikwad P; Dhawale A; Nambiar N; Gowri V; Pandrowala A; Taur P; Raj R; Uppuluri R; Sharma R; Kini P; Sivasankaran M; Munirathnam D; Vedam R; Vignesh P; Banday A; Rawat A; Aggarwal A; Poddar U; Girish M; Chaudhary A; Sampagar A; Jayaraman D; Chaudhary N; Shah N; Jijina F; Chandrakla S; Kanakia S; Arora B; Sen S; Lokeshwar M; Desai M; Madkaikar M
    Front Immunol; 2021; 12():612583. PubMed ID: 33746956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral
    Dettmer V; Bloom K; Gross M; Weissert K; Aichele P; Ehl S; Cathomen T
    Hum Gene Ther; 2019 Aug; 30(8):975-984. PubMed ID: 31032638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, immunological and genetic findings in patients with UNC13D deficiency (FHL3): A systematic review.
    Amirifar P; Ranjouri MR; Abolhassani H; Moeini Shad T; Almasi-Hashiani A; Azizi G; Moamer S; Aghamohammadi A; Yazdani R
    Pediatr Allergy Immunol; 2021 Jan; 32(1):186-197. PubMed ID: 32679608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and atypical splicing mutation in a compound heterozygous UNC13D defect presenting in Familial Hemophagocytic Lymphohistiocytosis triggered by EBV infection.
    Alsina L; Colobran R; de Sevilla MF; Català A; Viñas L; Ricart S; Plaza AM; Lois S; Juan M; Pujol-Borrell R; Martinez-Gallo M
    Clin Immunol; 2014 Aug; 153(2):292-7. PubMed ID: 24825797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel MUNC13-4 mutations in familial haemophagocytic lymphohistiocytosis and functional analysis of MUNC13-4-deficient cytotoxic T lymphocytes.
    Yamamoto K; Ishii E; Sako M; Ohga S; Furuno K; Suzuki N; Ueda I; Imayoshi M; Yamamoto S; Morimoto A; Takada H; Hara T; Imashuku S; Sasazuki T; Yasukawa M
    J Med Genet; 2004 Oct; 41(10):763-7. PubMed ID: 15466010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.
    Cichocki F; Schlums H; Li H; Stache V; Holmes T; Lenvik TR; Chiang SC; Miller JS; Meeths M; Anderson SK; Bryceson YT
    J Exp Med; 2014 Jun; 211(6):1079-91. PubMed ID: 24842371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.